comparemela.com

Latest Breaking News On - Ctinic - Page 1 : comparemela.com

Biofrontera Inc Announces Last Patient Out in Phase I Study to Evaluate Safety and Tolerability in Treating Actinic Keratosis Using 3 Tubes of Ameluz

WOBURN, MA / ACCESSWIRE / April 26, 2023 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that that the last

DelveInsight Business Research, LLP: Actinic Keratosis Market to Climb Swiftly at a 2 43% CAGR During the Study Period [2018-2030], Evaluates DelveInsight

LAS VEGAS, March 3, 2022 /PRNewswire/ The Actinic Keratosis Treatment Drugs produced by drug giants of the pharmaceuticals industry such as VDA-1102 (Vidac Pharma), DFD-07 (Promius Pharma)

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.